Insights on the Clinical Trial Imaging Market Report & Forecast to 2028 - by Players, Types, Applications and Region
QYResearch released a latest market research report on the Global Clinical Trial Imaging market, which is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the Global Clinical Trial Imaging market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
Scope of the Clinical Trial Imaging Market Report
The global Clinical Trial Imaging market size is projected to reach US$ 2197.88 million by 2028, from US$ 1379.44 million in 2021, at a CAGR of 6.71% during 2022-2028.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Clinical Trial Imaging market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Clinical Trial Imaging market.
Global Clinical Trial Imaging Scope and Market Size
Clinical Trial Imaging market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Clinical Trial Imaging market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2017-2028.
For more information about this report, visit
Key Questions Answered in This Report
How has the Global and United States Clinical Trial Imaging performed so far and how will it perform in the coming years?
What are the key regional markets?
What is the breakup of the market based on the Clinical Trial Imaging type?
What is the breakup of the market based on the application?
What is the breakup of the market size based on the region?
What is the breakup of the market based on the region Level & country Level?
Who are the key players of the Global and United States Clinical Trial Imaging?
Segments Covered in the Report
By Company
Clario
ICON
McLaren
Parexel
BioTelemetry
ProScan Imaging
Imaging Endpoints
Radiant Sage
Micron, Inc.
Intrinsic Imaging
Median Technologies
Cardiovascular Imaging Technologies
Banook Medical
IXICO
Segment by Type
In-house Imaging Service
Central Imaging Service
Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Academic Institutes
Others
By Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
India
Southeast Asia
Korea
Australia
Rest of Asia
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
South Africa
Rest of MEA
Key Topics Covered
1 REPORT OVERVIEW 1
1.1 STUDY SCOPE 1
1.2 MARKET ANALYSIS BY TYPE 2
1.2.1 GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE GROWTH RATE BY TYPE: 2017 VS 2021 VS 2028 2
1.2.2 IN-HOUSE IMAGING SERVICE 3
1.2.3 CENTRAL IMAGING SERVICE 4
1.3 MARKET BY APPLICATION 5
1.3.1 GLOBAL CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION: 2017 VS 2021 VS 2028 5
1.3.2 PHARMACEUTICAL COMPANIES 7
1.3.3 BIOTECHNOLOGY COMPANIES 7
1.3.4 ACADEMIC INSTITUTES 7
1.3.5 OTHERS 8
1.4 STUDY OBJECTIVES 8
1.5 YEARS CONSIDERED 9
2 GLOBAL GROWTH TRENDS 10
2.1 GLOBAL CLINICAL TRIAL IMAGING MARKET PERSPECTIVE (2017-2028) 10
2.2 CLINICAL TRIAL IMAGING GROWTH TRENDS BY REGION 11
2.2.1 CLINICAL TRIAL IMAGING MARKET SIZE BY REGION: 2017 VS 2021 VS 2028 11
2.2.2 CLINICAL TRIAL IMAGING HISTORIC MARKET SIZE BY REGION (2017-2022) 12
2.2.3 CLINICAL TRIAL IMAGING FORECASTED MARKET SIZE BY REGION (2023-2028) 13
2.3 CLINICAL TRIAL IMAGING MARKET DYNAMICS 14
2.3.1 CLINICAL TRIAL IMAGING INDUSTRY TRENDS 14
2.3.2 CLINICAL TRIAL IMAGING MARKET DRIVERS 14
2.3.3 CLINICAL TRIAL IMAGING MARKET CHALLENGES 15
2.3.4 PORTER鈥橲 FIVE FORCES ANALYSIS 15
3 COMPETITION LANDSCAPE BY KEY PLAYERS 17
3.1 GLOBAL TOP CLINICAL TRIAL IMAGING PLAYERS BY REVENUE 17
3.1.1 GLOBAL TOP CLINICAL TRIAL IMAGING PLAYERS BY REVENUE (2017-2022) 17
3.1.2 GLOBAL CLINICAL TRIAL IMAGING REVENUE MARKET SHARE BY PLAYERS (2017-2022) 18
3.2 GLOBAL CLINICAL TRIAL IMAGING MARKET SHARE BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) 19
3.3 PLAYERS COVERED: RANKING BY CLINICAL TRIAL IMAGING REVENUE 19
3.4 GLOBAL CLINICAL TRIAL IMAGING MARKET CONCENTRATION RATIO 20
3.4.1 GLOBAL CLINICAL TRIAL IMAGING MARKET CONCENTRATION RATIO (CR5) 20
3.4.2 GLOBAL TOP 3 AND TOP 5 COMPANIES BY CLINICAL TRIAL IMAGING REVENUE IN 2021 21
3.5 CLINICAL TRIAL IMAGING KEY PLAYERS HEAD OFFICE AND AREA SERVED 22
3.6 ESTABLISHED DATE OF CLINICAL TRIAL IMAGING MARKET PLAYERS 23
3.7 MERGERS & ACQUISITIONS, EXPANSION PLANS 23
4 CLINICAL TRIAL IMAGING BREAKDOWN DATA BY TYPE 25
4.1 GLOBAL CLINICAL TRIAL IMAGING HISTORIC MARKET SIZE BY TYPE (2017-2022) 25
4.2 GLOBAL CLINICAL TRIAL IMAGING FORECASTED MARKET SIZE BY TYPE (2023-2028) 25
5 CLINICAL TRIAL IMAGING BREAKDOWN DATA BY APPLICATION 27
5.1 GLOBAL CLINICAL TRIAL IMAGING HISTORIC MARKET SIZE BY APPLICATION (2017-2022) 27
5.2 GLOBAL CLINICAL TRIAL IMAGING FORECASTED MARKET SIZE BY APPLICATION (2023-2028) 28
6 NORTH AMERICA 29
6.1 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE (2017-2028) 29
6.2 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE 29
6.2.1 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2017-2022) 29
6.2.2 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2023-2028) 30
6.2.3 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SHARE BY TYPE (2017-2028) 30
6.3 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION 31
6.3.1 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2017-2022) 31
6.3.2 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2023-2028) 31
6.3.3 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION (2017-2028) 32
6.4 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY 32
6.4.1 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2017-2022) 32
6.4.2 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SHARE BY COUNTRY (2023-2028) 33
6.4.3 UNITED STATES 34
6.4.4 CANADA 34
6.4.5 MEXICO 35
7 EUROPE 36
7.1 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE (2017-2028) 36
7.2 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE 36
7.2.1 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2017-2022) 36
7.2.2 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2023-2028) 37
7.2.3 EUROPE CLINICAL TRIAL IMAGING MARKET SHARE BY TYPE (2017-2028) 37
7.3 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION 38
7.3.1 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2017-2022) 38
7.3.2 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2023-2028) 38
7.3.3 EUROPE CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION (2017-2028) 39
7.4 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY 39
7.4.1 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2017-2022) 39
7.4.2 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2023-2028) 40
7.4.3 GERMANY 41
7.4.4 FRANCE 41
7.4.5 U.K. 42
7.4.6 ITALY 42
7.4.7 RUSSIA 43
7.4.8 NORDIC COUNTRIES 43
8 ASIA-PACIFIC 44
8.1 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE (2017-2028) 44
8.2 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE 44
8.2.1 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2017-2022) 44
8.2.2 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2023-2028) 45
8.2.3 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SHARE BY TYPE (2017-2028) 45
8.3 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION 46
8.3.1 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2017-2022) 46
8.3.2 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2023-2028) 46
8.3.3 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION (2017-2028) 47
8.4 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY REGION 47
8.4.1 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY REGION (2017-2022) 47
8.4.2 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY REGION (2023-2028) 48
8.4.3 CHINA 49
8.4.4 JAPAN 49
8.4.5 KOREA 50
8.4.6 SOUTHEAST ASIA 50
8.4.7 INDIA 51
8.4.8 AUSTRALIA 51
9 SOUTH AMERICA 52
9.1 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE (2017-2028) 52
9.2 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE 52
9.2.1 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2017-2022) 52
9.2.2 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2023-2028) 53
9.2.3 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SHARE BY TYPE (2017-2028) 53
9.3 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION 54
9.3.1 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2017-2022) 54
9.3.2 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2023-2028) 54
9.3.3 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION (2017-2028) 55
9.4 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY 55
9.4.1 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2017-2022) 55
9.4.2 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2023-2028) 56
9.4.3 BRAZIL 57
10 MIDDLE EAST & AFRICA 58
10.1 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE (2017-2028) 58
10.2 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE 58
10.2.1 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2017-2022) 58
10.2.2 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2023-2028) 59
10.2.3 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SHARE BY TYPE (2017-2028) 59
10.3 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION 60
10.3.1 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2017-2022) 60
10.3.2 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2023-2028) 60
10.3.3 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION (2017-2028) 61
10.4 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY 61
10.4.1 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2017-2022) 61
10.4.2 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2023-2028) 62
10.4.3 GCC COUNTRIES 63
10.4.4 TURKEY 63
10.4.5 SOUTH AFRICA 64
11 KEY PLAYERS PROFILES 65
11.1 CLARIO 65
11.1.1 CLARIO COMPANY DETAILS 65
11.1.2 CLARIO BUSINESS OVERVIEW 65
11.1.3 CLARIO CLINICAL TRIAL IMAGING INTRODUCTION 66
11.1.4 CLARIO REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 68
11.1.5 CLARIO RECENT DEVELOPMENT 69
11.2 ICON 69
11.2.1 ICON COMPANY DETAILS 69
11.2.2 ICON BUSINESS OVERVIEW 70
11.2.3 ICON CLINICAL TRIAL IMAGING INTRODUCTION 70
11.2.4 ICON REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 71
11.2.5 ICON RECENT DEVELOPMENT 72
11.3 MCLAREN 72
11.3.1 MCLAREN COMPANY DETAILS 72
11.3.2 MCLAREN BUSINESS OVERVIEW 73
11.3.3 MCLAREN CLINICAL TRIAL IMAGING INTRODUCTION 73
11.3.4 MCLAREN REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 74
11.3.5 MCLAREN RECENT DEVELOPMENT 75
11.4 PAREXEL 75
11.4.1 PAREXEL COMPANY DETAILS 75
11.4.2 PAREXEL BUSINESS OVERVIEW 76
11.4.3 PAREXEL CLINICAL TRIAL IMAGING INTRODUCTION 76
11.4.4 PAREXEL REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 77
11.4.5 PAREXEL RECENT DEVELOPMENT 78
11.5 BIOTELEMETRY 79
11.5.1 BIOTELEMETRY COMPANY DETAILS 79
11.5.2 BIOTELEMETRY BUSINESS OVERVIEW 79
11.5.3 BIOTELEMETRY CLINICAL TRIAL IMAGING INTRODUCTION 79
11.5.4 BIOTELEMETRY REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 80
11.5.5 BIOTELEMETRY RECENT DEVELOPMENT 81
11.6 PROSCAN IMAGING 81
11.6.1 PROSCAN IMAGING COMPANY DETAILS 81
11.6.2 PROSCAN IMAGING BUSINESS OVERVIEW 81
11.6.3 PROSCAN IMAGING CLINICAL TRIAL IMAGING INTRODUCTION 82
11.6.4 PROSCAN IMAGING REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 83
11.6.5 PROSCAN IMAGING RECENT DEVELOPMENT 84
11.7 IMAGING ENDPOINTS 84
11.7.1 IMAGING ENDPOINTS COMPANY DETAILS 84
11.7.2 IMAGING ENDPOINTS BUSINESS OVERVIEW 85
11.7.3 IMAGING ENDPOINTS CLINICAL TRIAL IMAGING INTRODUCTION 85
11.7.4 IMAGING ENDPOINTS REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 87
11.7.5 IMAGING ENDPOINTS RECENT DEVELOPMENT 87
11.8 RADIANT SAGE 88
11.8.1 RADIANT SAGE COMPANY DETAILS 88
11.8.2 RADIANT SAGE BUSINESS OVERVIEW 88
11.8.3 RADIANT SAGE CLINICAL TRIAL IMAGING INTRODUCTION 88
11.8.4 RADIANT SAGE REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 89
11.9 MICRON, INC. 90
11.9.1 MICRON, INC. COMPANY DETAILS 90
11.9.2 MICRON, INC. BUSINESS OVERVIEW 90
11.9.3 MICRON, INC. CLINICAL TRIAL IMAGING INTRODUCTION 90
11.9.4 MICRON, INC. REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 91
11.9.5 MICRON, INC. RECENT DEVELOPMENT 92
11.10 INTRINSIC IMAGING 92
11.10.1 INTRINSIC IMAGING COMPANY DETAILS 92
11.10.2 INTRINSIC IMAGING BUSINESS OVERVIEW 93
11.10.3 INTRINSIC IMAGING CLINICAL TRIAL IMAGING INTRODUCTION 93
11.10.4 INTRINSIC IMAGING REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 94
11.10.5 INTRINSIC IMAGING RECENT DEVELOPMENT 94
11.11 MEDIAN TECHNOLOGIES 95
11.11.1 MEDIAN TECHNOLOGIES COMPANY DETAILS 95
11.11.2 MEDIAN TECHNOLOGIES BUSINESS OVERVIEW 95
11.11.3 MEDIAN TECHNOLOGIES CLINICAL TRIAL IMAGING INTRODUCTION 95
11.11.4 MEDIAN TECHNOLOGIES REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 96
11.11.5 MEDIAN TECHNOLOGIES RECENT DEVELOPMENT 97
11.12 CARDIOVASCULAR IMAGING TECHNOLOGIES 97
11.12.1 CARDIOVASCULAR IMAGING TECHNOLOGIES COMPANY DETAILS 97
11.12.2 CARDIOVASCULAR IMAGING TECHNOLOGIES BUSINESS OVERVIEW 98
11.12.3 CARDIOVASCULAR IMAGING TECHNOLOGIES CLINICAL TRIAL IMAGING INTRODUCTION 98
11.12.4 CARDIOVASCULAR IMAGING TECHNOLOGIES REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 99
11.13 BANOOK MEDICAL 100
11.13.1 BANOOK MEDICAL COMPANY DETAILS 100
11.13.2 BANOOK MEDICAL BUSINESS OVERVIEW 101
11.13.3 BANOOK MEDICAL CLINICAL TRIAL IMAGING INTRODUCTION 101
11.13.4 BANOOK MEDICAL REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 101
11.13.5 BANOOK MEDICAL RECENT DEVELOPMENT 102
11.14 IXICO 102
11.14.1 IXICO COMPANY DETAILS 102
11.14.2 IXICO BUSINESS OVERVIEW 103
11.14.3 IXICO CLINICAL TRIAL IMAGING INTRODUCTION 103
11.14.4 IXICO REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 104
11.14.5 IXICO RECENT DEVELOPMENT 105
12 ANALYST'S VIEWPOINTS/CONCLUSIONS 106
For more information about this report, visit
Any questions or requirements, please do not hesitate to contact us.
About Us:
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years’ experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let’s work closely with you and build a bold and better future.
Contact Us
QY Research
E-mail: global@qyresearch.com
Tel: +1-626-842-1666(US) +852-5808-0956 (HK)
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
Website: https://us.qyresearch.com